iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
₹2,282.3
(-1.24%)
Oct 7, 2026|03:53:09 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,960₹3.5 0%3,0000%
3750%₹340 0%2,000₹3.4 -20.93%16,500-15.38%
--2,040₹8 0%9,0000%
--2,080₹6.05 -3.2%9,000-4%
--2,100₹7.45 3.47%79,125-19.77%
00%₹203.05 0%2,120₹9 4.04%13,8750%
--2,140₹10.7 2.39%29,250100%
00%₹181.55 0%2,160₹13.55 7.96%10,125-3.57%
--2,180₹15.35 0.65%15,3750%
2,62516.66%₹126.05 -10.69%2,200₹21.55 16.8%1,63,1251.87%
00%₹259.45 0%2,220₹25.35 13.42%17,625-11.32%
2,2500%₹127.95 0%2,240₹30.3 11.19%22,50015.38%
3,3750%₹81.2 -65.06%2,260₹38.1 15.98%34,50024.32%
21,3757.54%₹69.85 -15.38%2,280₹45.95 15.88%40,8753.80%
2,40,37513.05%₹56.05 -20.49%2,300₹55.6 17.42%1,13,25016.60%
55,12516.66%₹46.2 -23%2,320₹65.6 15.39%27,0009.09%
41,25010%₹38.65 -23.91%2,340₹65.15 -1.36%37,1250%
47,62519.81%₹32 -24.26%2,360₹94.35 -1.3%27,0000%
1,59,7502.89%₹26.2 -25.14%2,380₹113.1 0%48,7500%
3,42,37511.88%₹21.45 -26.28%2,400₹104.75 0%78,7500%
18,75035.13%₹18.25 -23.15%2,420₹98.5 0%1,8750%
37,5009.89%₹15.05 -22.42%2,440₹165.3 0%42,3750%
54,0004.34%₹12.55 -21.56%2,460₹176 0%5,2500%
60,0006.66%₹10.45 -22.01%2,480₹144.9 0%3,0000%
2,77,8756.77%₹8.8 -23.14%2,500₹189 0%17,2500%
28,5000%₹7.45 -20.32%2,520₹159.65 0%1,5000%
14,62514.70%₹6.35 -19.1%2,540₹207.15 0%00%
8,6250%₹5.55 0%2,560₹385.35 0%00%
10,1250%₹4.8 0%2,580₹267 0%1,8750%
46,8754.16%₹4.2 -19.23%2,600₹180 0%3750%
16,1250%₹4.05 0%2,620₹261.75 0%00%
1,1250%₹5.9 0%2,640₹325 0%2,2500%
2,6250%₹3.6 0%2,660₹291.25 0%00%
00%₹30.55 0%2,680₹485.7 0%00%
19,5000%₹3.05 0%2,700₹322 0%00%
7500%₹15 0%2,720₹520.55 0%00%
00%₹42.3 0%2,740₹402 0%2,6250%
2,6250%₹2.35 -12.96%2,760₹556.05 0%00%
5,2500%₹1.8 0%2,800₹592.1 0%00%
1,875-28.57%₹1.75 16.66%2,840₹538.05 0%15,0000%

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.